Tonix Pharmaceuticals Stock News

Tonix Pharmaceuticals Holding Corp (TNXP) shares closed today at 0.7% above its 52 week low of $0.36, giving the company a market cap of $180M. The stock is currently down 46.0% year-to-date, down 44.4% over the past 12 months, and down 99.9% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 26.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -2905.8% The company's stock price performance over the past 12 months lags the peer average by -1870.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with the stream of -0.32% also noticed, India Paysafe Limited (NYSE:PSFE) encountered a rapid change of 5.44% in the last hour of Thursdays trading session. The post Analyzing Analysts Recommendations: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Paysafe Limited (NYSE:PSFE) appeared first on Stocks Equity .

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with the stream of -1.51% also noticed, India Nu Holdings Ltd. (NYSE:NU) encountered a rapid change of 3.24% in the last hour of Tuesdays trading The post Will Shareholder Love To Invest in This Stock? Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Nu Holdings Ltd. (NYSE:NU) appeared first on Stocks Equity .

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Stock analysts at Zacks Investment Research lifted their FY2021 EPS estimates for Tonix Pharmaceuticals in a report released on Monday, December 13th. Zacks Investment Research analyst D. Bautz now forecasts that the company will post earnings per share of ($0.26) for the year, up from their previous estimate of [] The post FY2021 Earnings Forecast for Tonix Pharmaceuticals Holding Corp. Issued By Zacks Investment Research (NASDAQ:TNXP) appeared first on ETF Daily News .

Brokerages predict that Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) will announce ($0.06) earnings per share for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Tonix Pharmaceuticals earnings. The highest EPS estimate is ($0.05) and the lowest is ($0.07). Tonix Pharmaceuticals reported earnings of ($0.10) per share in the same quarter last []

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with the stream of -5.53% also noticed, India Devon Energy Corporation (NYSE:DVN) encountered a rapid change of 0.95% in the last hour of Thursdays trading The post Important Factors to Analyze A Good Investment: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Devon Energy Corporation (NYSE:DVN) appeared first on Stocks Equity .

You'd pop the champagne, too, if you were included on a major industry stock index.

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Vir Biotech Says COVID-19 Antibody Treatment Effective Against Omicron Variant Vir Biotechnology, Inc.

CHATHAM, N.J., Dec. 15, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has been added to the Nasdaq Biotechnology Index (Nasdaq: NBI) as part of the Nasdaqs annual reconstitution process. The addition will become effective prior to market open on Monday, December 20, 2021.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with the stream of -3.61% also noticed, India Eros STX Global Corporation (NYSE:ESGC) encountered a rapid change of -10.84% in the last hour of Tuesdays The post Which Option is Best? Buy or Sell: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Eros STX Global Corporation (NYSE:ESGC) appeared first on Stocks Equity .

First-in-Human Study Expected to be Initiated in the First Quarter of 2022

First-in-Human Study Expected to be Initiated in the First Quarter of 2022 An Approved Test Would Lead to Identification of People Requiring Vaccine Boosters CHATHAM, N.J., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP ) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application to initiate a first-in-human clinical study for TNX-2100 (SARS-CoV-2 epitope peptide mixtures for intradermal administration), a skin test to measure delayed-type hypersensitivity (DTH) to SARS-CoV-2 (CoV-2), the virus that causes COVID-19. DTH is a measure of T cell immunity. Tonix expects to initiate the clinical study in the first quarter of 2022. "When fully developed, our proposed skin test has the potential to provide clinicians, patients, employers and public health officials with important diagnostic, safety and predictive information, including the durability of immune responses in vaccinated, convalescent and exposed individuals," stated Seth Lederman, M.D., President and Chief Executive Officer of Tonix. "One of the goals of clinical development of TNX-2100 will be to study the potential correlation of a positive skin test with protective immunity.

The trading price of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) closed lower on Friday, December 10, closing at $0.38, -4.42% lower than its previous close. >> 7 Top Picks for the Post-Pandemic Economy

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) with the stream of -4.42% also noticed, India Trevi Therapeutics, Inc. (NASDAQ:TRVI) encountered a rapid change of 0.40% in the last hour of Fridays trading The post Hot Stocks Highlights: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), Trevi Therapeutics, Inc. (NASDAQ:TRVI) appeared first on Stocks Equity .

Millennium Management LLC lowered its stake in shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) by 15.7% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 830,208 shares of the companys stock after selling 154,243 shares during the quarter. Millennium Management LLCs []